Skip to content

Clinical trials

Observational Gastrointestinal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Observational Country / region: United States Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20061
20072
20081
20105
20115
20122
20131
20143
20151
20163
20172
20182
20194
20205
20214
20225
20235
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting15
Terminated7
Active, not recruiting6
Unknown status3
Not yet recruiting2
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exact Sciences Corporation6
National Cancer Institute (NCI)6
M.D. Anderson Cancer Center4
Baylor College of Medicine3
Mayo Clinic3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
City of Hope Medical Center2
Memorial Sloan Kettering Cancer Center2
Stanford University2
University of Southern California2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms64
Neoplasms20
Lung Neoplasms16
Colorectal Neoplasms15
Breast Neoplasms14
Pancreatic Neoplasms12
Head and Neck Neoplasms11
Colonic Diseases10
Esophageal Neoplasms10
Gastrointestinal Diseases10

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.